Protego Biopharma, Inc.

CIK 1796909 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Protego Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Dec 3, 2025D0001231919-25-000568
Oct 28, 2021D0001796909-21-000002
Dec 17, 2019D0001796909-19-000001